About Flarin
Flarin is a Healthcare company based in London (United Kingdom) founded in 2012. It operates as a joint pain drugs are manufactured by Flarin in the UK. The company has 4 employees. Flarin offers products and services including Flarin Ibuprofen Capsules and Lipid Lock Technology. Its focus areas include Traditional Pharmaceuticals. Its legal entity is infirst Ltd.
Company details
Flarin was established in 2012 as a pharmaceutical entity focused on joint pain treatments. Operations are centered in London, United Kingdom, where formulations for joint relief medications are developed and produced. The company operates within the healthcare sector, emphasizing drug manufacturing for pain management. Distribution occurs through the domain flarin.co.uk, serving markets in the region with targeted therapeutic products.
- Headquarters London, United Kingdom
- Employees 4
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website flarin.co.uk
- Social LinkedIn X Facebook Instagram
- Legal Name Infirst Ltd
- InvestorsITV plc
& 1 more
- Employee Count4
Products & Services of Flarin
Flarin offers a comprehensive portfolio of products and services, including Flarin Ibuprofen Capsules and Lipid Lock Technology.
These capsules are formulated with lipids to provide relief from joint pain and inflammation by targeting areas where prostaglandins are produced.
This technology is employed to protect ibuprofen in a lipid formulation, enabling it to be absorbed in the small intestine for effective delivery to pain sites.
Funding Insights of Flarin
- Total Rounds 3
- Investors Count 2
All 3 funding rounds of Flarin with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | – | Series A | – | ITV | |
| Apr 2021 | – | Seed | – | IW Capital | – |
| Jun 2019 | – | Seed | – | IW Capital | – |
2 investors in total: 2 institutional.
Investors in Flarin
Flarin has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include ITV plc and IW Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward small and medium-sized enterprises. | – | iwcapital.co.uk | London, United Kingdom | |
High-quality television content is produced, broadcasted, and streamed globally. | 1954 | itvplc.com | London, United Kingdom |
Investor details for Flarin
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Flarin
3 dated milestones of Flarin across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Flarin is founded.
- Funding First funding round.
- Funding Latest funding round, Series A,.
Web traffic of Flarin
The website of Flarin (flarin.co.uk) receives about 9.6K visits a month.
- Monthly visits9.6K
▼ 29.7% vs previous month
Websites whose visitors overlap most with Flarin. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ultracarepro.in | 100% | 43.4K | #832,543 | View details | |
| lloydspharmacy.com | 66% | 1.2M | #46,107 | View details |
Top companies in Traditional Health & Nutrition
10 companies that operate in the same segment as Flarin (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Flarin
Flarin was founded in 2012 and raised its 1st funding round 7 years after it was founded.
Flarin is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Flarin has 4 employees.
Flarin was established in 2012 as a pharmaceutical entity focused on joint pain treatments. Operations are centered in London, United Kingdom, where formulations for joint relief medications are developed and produced. The company operates within the healthcare sector, emphasizing drug manufacturing for pain management. Distribution occurs through the domain flarin.co.uk, serving markets in the region with targeted therapeutic products.
Flarin offers Flarin Ibuprofen Capsules and Lipid Lock Technology.
Flarin has 2 investors. Key investors include ITV plc, and IW Capital.
Flarin operates through Infirst Ltd.